Indication

Granulomatosis infantiseptica

Granulomatosis infantiseptica is a severe, life-threatening form of early-onset neonatal listeriosis resulting from transplacental transmission of *Listeria monocytogenes* during maternal bacteremia. Read more about Granulomatosis infantiseptica

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Granulomatosis infantiseptica therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Granulomatosis infantiseptica preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Granulomatosis infantiseptica.

Granulomatosis infantiseptica is a severe, life-threatening form of early-onset neonatal listeriosis resulting from transplacental transmission of *Listeria monocytogenes* during maternal bacteremia.

The condition primarily affects fetuses and neonates, manifesting in utero or within the first hours to days of life with fulminant septicemia and multisystem involvement.

Pathophysiologically, it is characterized by hematogenous dissemination leading to widespread pyogranulomatous lesions and microabscesses throughout internal organs—predominantly the liver, spleen, lungs, adrenal glands, and central nervous system—often accompanied by characteristic papular or petechial cutaneous eruptions.

Personalize your experience

Follow Granulomatosis infantiseptica and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it